Literature DB >> 8268912

Characterization and chromosomal localization of the human proto-oncogene BMI-1.

M J Alkema1, J Wiegant, A K Raap, A Berns, M van Lohuizen.   

Abstract

The proto-oncogene bmi-1 is frequently activated by Moloney murine leukemia proviral insertions in E mu-myc transgenic mice1,2. Using a mouse bmi-1 cDNA probe a transcript of 3.3 kb was detected on Northern blots of human Burkitt's lymphoma cell lines. We have isolated and sequenced cDNA clones from a human erythroleukemia cell line (K562) derived cDNA library, using different mouse bmi-1 cDNA fragments as a probe. Analysis of genomic BMI-1 sequences reveals a gene structure which is very similar to that of the mouse, consisting of at least 10 exons. The human cDNA is 3203 bp in length and shows 86% identity to the mouse nucleotide sequence. The open reading frame encodes a protein of 326 amino acids which shares 98% identity to the amino acid sequence of mouse bmi-1 protein. In vitro translation experiments show that human cDNA derived RNA translates into a protein with a mobility of 44-46 kD on SDS polyacrylamide gels. Fluorescence in situ hybridization (FISH) on metaphase chromosome spreads located the human BMI-1 gene to the short arm of chromosome 10 (10p13), a region known to be involved in translocations in various leukemias.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8268912     DOI: 10.1093/hmg/2.10.1597

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  35 in total

Review 1.  Embryonic stem cell-specific signature in cervical cancer.

Authors:  Jorge Organista-Nava; Yazmín Gómez-Gómez; Patricio Gariglio
Journal:  Tumour Biol       Date:  2013-10-28

2.  Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes.

Authors:  R G Sewalt; J van der Vlag; M J Gunster; K M Hamer; J L den Blaauwen; D P Satijn; T Hendrix; R van Driel; A P Otte
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

3.  Molecular genetic analysis of Suppressor 2 of zeste identifies key functional domains.

Authors:  Richard B Emmons; Heather Genetti; Stephen Filandrinos; Jillian Lokere; Chao-ting Wu
Journal:  Genetics       Date:  2009-06-15       Impact factor: 4.562

4.  BMI1 suffers a degrading experience.

Authors:  Mark Hoenerhoff; Isabel M Chu; Jeffrey E Green
Journal:  Cell Cycle       Date:  2011-06-15       Impact factor: 4.534

5.  RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor.

Authors:  D P Satijn; M J Gunster; J van der Vlag; K M Hamer; W Schul; M J Alkema; A J Saurin; P S Freemont; R van Driel; A P Otte
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

6.  BMI-1 is highly expressed in M0-subtype acute myeloid leukemia.

Authors:  Masashi Sawa; Kazuhito Yamamoto; Toshiya Yokozawa; Hitoshi Kiyoi; Asahi Hishida; Tomohiro Kajiguchi; Masao Seto; Akio Kohno; Kunio Kitamura; Yoshie Itoh; Norio Asou; Nobuyuki Hamajima; Nobuhiko Emi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

7.  Transformation by the Bmi-1 oncoprotein correlates with its subnuclear localization but not its transcriptional suppression activity.

Authors:  K J Cohen; J S Hanna; J E Prescott; C V Dang
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

8.  The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family.

Authors:  M H Dreyling; J A Martinez-Climent; M Zheng; J Mao; J D Rowley; S K Bohlander
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

9.  Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma.

Authors:  You-Wei Lu; Jin Li; Wei-Jian Guo
Journal:  J Exp Clin Cancer Res       Date:  2010-11-08

10.  Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer.

Authors:  H Nalwoga; J B Arnes; H Wabinga; L A Akslen
Journal:  Br J Cancer       Date:  2009-12-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.